HealthManagement, Volume 3 - Issue 1, 2009

Medtronic announced that a federal US district court jury in San Francisco awarded it 57 million dollars in past damages, finding that AGA Medical Corp.’s manufacture, sale and use of its Amplatzer® Occluder and vascular plug product lines infringed claims of two US patents owned by Medtronic. The jury also ordered that AGA pay Medtronic a royalty of 11 percent on future US sales of the infringing products through 2018. Medtronic is also asserting these same patents against W.L. Gore & Associates, Inc. in another case.

«« Study Proves Smoking Ban Effective


Abbott Begins U.S. Study Drug Eluting Stent Designed for Small Vessels »»